Požymis
Swollen lymph nodes
Klinikinis pavadinimas: Lymphadenopathy
Enlargement (swelling) of a lymph node.
Santrauka
- Taip pat vadinama
- Lymph node hyperplasia
Ši puslapis kaip duomenys
Norėdami perskaityti jį kaip JSON, pridėkite .json prie puslapio adreso arba nurodykite application/json.
library(jsonlite)
url <- "https://dantelabs.com/traits/lymphadenopathy.json"
page <- fromJSON(url)
page$trait$nameVienu tyrimu sužinokite genus, susijusius su Swollen lymph nodes, ir kitą jūsų genomo dalį.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test236 genų susiję su Swollen lymph nodes
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Swollen lymph nodes. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| CASP10caspase 10 | Visada | 2 ligose |
| CASP8caspase 8 | Visada | 1 ligoje |
| CD70CD70 molecule | Visada | 1 ligoje |
| CTNNBL1catenin beta like 1 | Visada | 1 ligoje |
| CYBC1cytochrome b-245 chaperone 1 | Visada | 1 ligoje |
| HMOX1heme oxygenase 1 | Visada | 1 ligoje |
| IKZF2IKAROS family zinc finger 2 | Visada | 1 ligoje |
| IL2RAinterleukin 2 receptor subunit alpha | Visada | 2 ligose |
| IL6STinterleukin 6 cytokine family signal transducer | Visada | 1 ligoje |
| IRF8interferon regulatory factor 8 | Visada | 2 ligose |
| ITKIL2 inducible T cell kinase | Visada | 1 ligoje |
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Visada | 1 ligoje |
| LATlinker for activation of T cells | Visada | 1 ligoje |
| MAGT1magnesium transporter 1 | Visada | 1 ligoje |
| MCTS1MCTS1 re-initiation and release factor | Visada | 1 ligoje |
| NBNnibrin | Visada | 1 ligoje |
| NCKAP1LNCK associated protein 1 like | Visada | 1 ligoje |
| NLRP3NLR family pyrin domain containing 3 | Visada | 3 ligose |
| PLD4phospholipase D family member 4 | Visada | 1 ligoje |
| POLD3DNA polymerase delta 3, accessory subunit | Visada | 1 ligoje |
| PRKCDprotein kinase C delta | Visada | 1 ligoje |
| PSMG2proteasome assembly chaperone 2 | Visada | 1 ligoje |
| RASGRP1RAS guanyl releasing protein 1 | Visada | 1 ligoje |
| RC3H1ring finger and CCCH-type domains 1 | Visada | 1 ligoje |
| SHARPINSHANK associated RH domain interactor | Visada | 1 ligoje |
| SLC29A3solute carrier family 29 member 3 | Visada | 2 ligose |
| STXBP2syntaxin binding protein 2 | Visada | 2 ligose |
| TET2tet methylcytosine dioxygenase 2 | Visada | 4 ligose |
| TPP2tripeptidyl peptidase 2 | Visada | 2 ligose |
| TRACT cell receptor alpha constant | Visada | 1 ligoje |
| TRAF3TNF receptor associated factor 3 | Visada | 1 ligoje |
| UNGuracil DNA glycosylase | Visada | 1 ligoje |
| ZAP70zeta chain of T cell receptor associated protein kinase 70 | Visada | 2 ligose |
| ADAadenosine deaminase | Labai dažnai (80–99%) | 1 ligoje |
| ATMATM serine/threonine kinase | Labai dažnai (80–99%) | 1 ligoje |
| BCL2BCL2 apoptosis regulator | Labai dažnai (80–99%) | 1 ligoje |
| BCL6BCL6 transcription repressor | Labai dažnai (80–99%) | 1 ligoje |
| CCND1cyclin D1 | Labai dažnai (80–99%) | 2 ligose |
| CD28CD28 molecule | Labai dažnai (80–99%) | 2 ligose |
| CHD7chromodomain helicase DNA binding protein 7 | Labai dažnai (80–99%) | 1 ligoje |
Rodyti dar 196 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| CLCN7Cl-/H+ antiporter 7 | Labai dažnai (80–99%) | 1 ligoje |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Labai dažnai (80–99%) | 5 ligose |
| DCLRE1CDNA cross-link repair 1C | Labai dažnai (80–99%) | 2 ligose |
| EIF2AK4eukaryotic translation initiation factor 2 alpha kinase 4 | Labai dažnai (80–99%) | 1 ligoje |
| EWSR1EWS RNA binding protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| FASFas cell surface death receptor | Labai dažnai (80–99%) | 2 ligose |
| FASLGFas ligand | Labai dažnai (80–99%) | 1 ligoje |
| GINS1GINS complex subunit 1 | Labai dažnai (80–99%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Labai dažnai (80–99%) | 4 ligose |
| IGHimmunoglobulin heavy locus | Labai dažnai (80–99%) | 3 ligose |
| IL2RGinterleukin 2 receptor subunit gamma | Labai dažnai (80–99%) | 1 ligoje |
| IL7Rinterleukin 7 receptor | Labai dažnai (80–99%) | 3 ligose |
| MVKmevalonate kinase | Labai dažnai (80–99%) | 3 ligose |
| NUDCD3NudC domain containing 3 | Labai dažnai (80–99%) | 1 ligoje |
| OSTM1osteoclastogenesis associated transmembrane protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| PSMB10proteasome 20S subunit beta 10 | Labai dažnai (80–99%) | 1 ligoje |
| RAG1recombination activating 1 | Labai dažnai (80–99%) | 2 ligose |
| RAG2recombination activating 2 | Labai dažnai (80–99%) | 2 ligose |
| RIPK1receptor interacting serine/threonine kinase 1 | Labai dažnai (80–99%) | 1 ligoje |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Labai dažnai (80–99%) | 1 ligoje |
| SNX10sorting nexin 10 | Labai dažnai (80–99%) | 1 ligoje |
| TCIRG1T cell immune regulator 1, ATPase H+ transporting V0 subunit a3 | Labai dažnai (80–99%) | 1 ligoje |
| TNFRSF1BTNF receptor superfamily member 1B | Labai dažnai (80–99%) | 2 ligose |
| TNFSF11TNF superfamily member 11 | Labai dažnai (80–99%) | 1 ligoje |
| WT1WT1 transcription factor | Labai dažnai (80–99%) | 2 ligose |
| ADA2adenosine deaminase 2 | Dažnai (30–79%) | 1 ligoje |
| ADAMTS3ADAM metallopeptidase with thrombospondin type 1 motif 3 | Dažnai (30–79%) | 1 ligoje |
| AICDAactivation induced cytidine deaminase | Dažnai (30–79%) | 1 ligoje |
| ALKALK receptor tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| ASXL1ASXL transcriptional regulator 1 | Dažnai (30–79%) | 2 ligose |
| BRCA1BRCA1 DNA repair associated | Dažnai (30–79%) | 1 ligoje |
| BRCA2BRCA2 DNA repair associated | Dažnai (30–79%) | 2 ligose |
| CBLCbl proto-oncogene | Dažnai (30–79%) | 1 ligoje |
| CCBE1collagen and calcium binding EGF domains 1 | Dažnai (30–79%) | 1 ligoje |
| CD27CD27 molecule | Dažnai (30–79%) | 1 ligoje |
| CDKN2Acyclin dependent kinase inhibitor 2A | Dažnai (30–79%) | 1 ligoje |
| ELANEelastase, neutrophil expressed | Dažnai (30–79%) | 1 ligoje |
| FAT4FAT atypical cadherin 4 | Dažnai (30–79%) | 1 ligoje |
| FCHO1FCH and mu domain containing endocytic adaptor 1 | Dažnai (30–79%) | 1 ligoje |
| HACE1HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Dažnai (30–79%) | 1 ligoje |
| IL6interleukin 6 | Dažnai (30–79%) | 1 ligoje |
| IRAK1interleukin 1 receptor associated kinase 1 | Dažnai (30–79%) | 2 ligose |
| ISG15ISG15 ubiquitin like modifier | Dažnai (30–79%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Dažnai (30–79%) | 1 ligoje |
| LACC1laccase domain multifunctional purine nucleosidase 1 | Dažnai (30–79%) | 1 ligoje |
| LIN28Blin-28 RNA binding posttranscriptional regulator B | Dažnai (30–79%) | 1 ligoje |
| LMO1LIM domain only 1 | Dažnai (30–79%) | 1 ligoje |
| MAP2K1mitogen-activated protein kinase kinase 1 | Dažnai (30–79%) | 1 ligoje |
| MIFmacrophage migration inhibitory factor | Dažnai (30–79%) | 1 ligoje |
| MYCNMYCN proto-oncogene, bHLH transcription factor | Dažnai (30–79%) | 1 ligoje |
| NLRP12NLR family pyrin domain containing 12 | Dažnai (30–79%) | 1 ligoje |
| NRASNRAS proto-oncogene, GTPase | Dažnai (30–79%) | 1 ligoje |
| OTULINOTU deubiquitinase with linear linkage specificity | Dažnai (30–79%) | 1 ligoje |
| PALB2partner and localizer of BRCA2 | Dažnai (30–79%) | 1 ligoje |
| PALLDpalladin, cytoskeletal associated protein | Dažnai (30–79%) | 1 ligoje |
| PHOX2Bpaired like homeobox 2B | Dažnai (30–79%) | 1 ligoje |
| PIK3CDphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | Dažnai (30–79%) | 2 ligose |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Dažnai (30–79%) | 1 ligoje |
| PRF1perforin 1 | Dažnai (30–79%) | 2 ligose |
| PSMB8proteasome 20S subunit beta 8 | Dažnai (30–79%) | 1 ligoje |
| PSTPIP1proline-serine-threonine phosphatase interacting protein 1 | Dažnai (30–79%) | 1 ligoje |
| RAB27ARAB27A, member RAS oncogene family | Dažnai (30–79%) | 1 ligoje |
| RABL3RAB, member of RAS oncogene family like 3 | Dažnai (30–79%) | 1 ligoje |
| RBCK1RANBP2-type and C3HC4-type zinc finger containing 1 | Dažnai (30–79%) | 1 ligoje |
| RNU4ATACRNA, U4atac small nuclear | Dažnai (30–79%) | 2 ligose |
| RUNX1RUNX family transcription factor 1 | Dažnai (30–79%) | 1 ligoje |
| SAT1spermidine/spermine N1-acetyltransferase 1 | Dažnai (30–79%) | 1 ligoje |
| SMAD4SMAD family member 4 | Dažnai (30–79%) | 1 ligoje |
| SPP1secreted phosphoprotein 1 | Dažnai (30–79%) | 2 ligose |
| SRSF2serine and arginine rich splicing factor 2 | Dažnai (30–79%) | 2 ligose |
| STAT1signal transducer and activator of transcription 1 | Dažnai (30–79%) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Dažnai (30–79%) | 4 ligose |
| STIM1stromal interaction molecule 1 | Dažnai (30–79%) | 1 ligoje |
| STX11syntaxin 11 | Dažnai (30–79%) | 2 ligose |
| SYKspleen associated tyrosine kinase | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 1 ligoje |
| TLR8toll like receptor 8 | Dažnai (30–79%) | 1 ligoje |
| TNFRSF1ATNF receptor superfamily member 1A | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 1 ligoje |
| TSC1TSC complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Dažnai (30–79%) | 1 ligoje |
| UNC13Dunc-13 homolog D | Dažnai (30–79%) | 1 ligoje |
| WDR1WD repeat domain 1 | Dažnai (30–79%) | 1 ligoje |
| YARS1tyrosyl-tRNA synthetase 1 | Dažnai (30–79%) | 1 ligoje |
| ZNFX1zinc finger NFX1-type containing 1 | Dažnai (30–79%) | 1 ligoje |
| ANKRD55ankyrin repeat domain 55 | Kartais (5–29%) | 1 ligoje |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Kartais (5–29%) | 1 ligoje |
| BAP1BRCA1 associated deubiquitinase 1 | Kartais (5–29%) | 1 ligoje |
| BCL10BCL10 immune signaling adaptor | Kartais (5–29%) | 1 ligoje |
| BCORBCL6 corepressor | Kartais (5–29%) | 1 ligoje |
| BIRC3baculoviral IAP repeat containing 3 | Kartais (5–29%) | 1 ligoje |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| BTNL2butyrophilin like 2 | Kartais (5–29%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Kartais (5–29%) | 2 ligose |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Kartais (5–29%) | 1 ligoje |
| CALRcalreticulin | Kartais (5–29%) | 1 ligoje |
| CCR1C-C motif chemokine receptor 1 | Kartais (5–29%) | 1 ligoje |
| CD247CD247 molecule | Kartais (5–29%) | 1 ligoje |
| CR2complement C3d receptor 2 | Kartais (5–29%) | 2 ligose |
| CTR9CTR9 component of Paf1/RNA polymerase II complex | Kartais (5–29%) | 1 ligoje |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Kartais (5–29%) | 1 ligoje |
| DLEC1DLEC1 cilia and flagella associated protein | Kartais (5–29%) | 1 ligoje |
| DNASE1deoxyribonuclease 1 | Kartais (5–29%) | 1 ligoje |
| DNASE1L3deoxyribonuclease 1L3 | Kartais (5–29%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Kartais (5–29%) | 1 ligoje |
| ERBB2erb-b2 receptor tyrosine kinase 2 | Kartais (5–29%) | 1 ligoje |
| ETS1ETS proto-oncogene 1, transcription factor | Kartais (5–29%) | 1 ligoje |
| FCGR2BFc gamma receptor IIb | Kartais (5–29%) | 1 ligoje |
| FCGR3BFc gamma receptor IIIb | Kartais (5–29%) | 1 ligoje |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Kartais (5–29%) | 1 ligoje |
| FOXN1forkhead box N1 | Kartais (5–29%) | 1 ligoje |
| FOXP1forkhead box P1 | Kartais (5–29%) | 1 ligoje |
| FOXP3forkhead box P3 | Kartais (5–29%) | 2 ligose |
| GATA2GATA binding protein 2 | Kartais (5–29%) | 1 ligoje |
| GPC3glypican 3 | Kartais (5–29%) | 1 ligoje |
| H19H19 imprinted maternally expressed transcript | Kartais (5–29%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 1 ligoje |
| IFNGR1interferon gamma receptor 1 | Kartais (5–29%) | 2 ligose |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Kartais (5–29%) | 1 ligoje |
| IL10interleukin 10 | Kartais (5–29%) | 2 ligose |
| IL12Ainterleukin 12A | Kartais (5–29%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Kartais (5–29%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Kartais (5–29%) | 1 ligoje |
| IL2RBinterleukin 2 receptor subunit beta | Kartais (5–29%) | 2 ligose |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Kartais (5–29%) | 1 ligoje |
| IRF4interferon regulatory factor 4 | Kartais (5–29%) | 1 ligoje |
| IRF5interferon regulatory factor 5 | Kartais (5–29%) | 1 ligoje |
| ITGAMintegrin subunit alpha M | Kartais (5–29%) | 1 ligoje |
| JAK2Janus kinase 2 | Kartais (5–29%) | 1 ligoje |
| JAZF1JAZF zinc finger 1 | Kartais (5–29%) | 1 ligoje |
| KIAA0319LKIAA0319 like | Kartais (5–29%) | 1 ligoje |
| KITKIT proto-oncogene, receptor tyrosine kinase | Kartais (5–29%) | 2 ligose |
| KLRC4killer cell lectin like receptor C4 | Kartais (5–29%) | 1 ligoje |
| LCATlecithin-cholesterol acyltransferase | Kartais (5–29%) | 1 ligoje |
| LIG4DNA ligase 4 | Kartais (5–29%) | 1 ligoje |
| LRBALPS responsive beige-like anchor protein | Kartais (5–29%) | 1 ligoje |
| LYSTlysosomal trafficking regulator | Kartais (5–29%) | 2 ligose |
| MALT1MALT1 paracaspase | Kartais (5–29%) | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Kartais (5–29%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Kartais (5–29%) | 2 ligose |
| MPLMPL proto-oncogene, thrombopoietin receptor | Kartais (5–29%) | 1 ligoje |
| MYD88MYD88 innate immune signal transduction adaptor | Kartais (5–29%) | 1 ligoje |
| NABP1nucleic acid binding protein 1 | Kartais (5–29%) | 1 ligoje |
| NOD2nucleotide binding oligomerization domain containing 2 | Kartais (5–29%) | 1 ligoje |
| NPM1nucleophosmin 1 | Kartais (5–29%) | 1 ligoje |
| NUMA1nuclear mitotic apparatus protein 1 | Kartais (5–29%) | 1 ligoje |
| PDCD1programmed cell death 1 | Kartais (5–29%) | 1 ligoje |
| PMLPML nuclear body scaffold | Kartais (5–29%) | 1 ligoje |
| POU6F2POU class 6 homeobox 2 | Kartais (5–29%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Kartais (5–29%) | 1 ligoje |
| PTPN2protein tyrosine phosphatase non-receptor type 2 | Kartais (5–29%) | 1 ligoje |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Kartais (5–29%) | 2 ligose |
| PXKPX domain containing serine/threonine kinase like | Kartais (5–29%) | 1 ligoje |
| RARAretinoic acid receptor alpha | Kartais (5–29%) | 1 ligoje |
| RESTRE1 silencing transcription factor | Kartais (5–29%) | 1 ligoje |
| RNF6ring finger protein 6 | Kartais (5–29%) | 1 ligoje |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Kartais (5–29%) | 1 ligoje |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Kartais (5–29%) | 1 ligoje |
| SDHCsuccinate dehydrogenase complex subunit C | Kartais (5–29%) | 1 ligoje |
| SOCS1suppressor of cytokine signaling 1 | Kartais (5–29%) | 1 ligoje |
| STAT3signal transducer and activator of transcription 3 | Kartais (5–29%) | 1 ligoje |
| STAT5Bsignal transducer and activator of transcription 5B | Kartais (5–29%) | 1 ligoje |
| TBL1XR1TBL1X/Y related 1 | Kartais (5–29%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Kartais (5–29%) | 1 ligoje |
| TLR4toll like receptor 4 | Kartais (5–29%) | 1 ligoje |
| TLR7toll like receptor 7 | Kartais (5–29%) | 1 ligoje |
| TNFAIP3TNF alpha induced protein 3 | Kartais (5–29%) | 1 ligoje |
| TNFSF4TNF superfamily member 4 | Kartais (5–29%) | 1 ligoje |
| TNIP1TNFAIP3 interacting protein 1 | Kartais (5–29%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Kartais (5–29%) | 1 ligoje |
| TRIM28tripartite motif containing 28 | Kartais (5–29%) | 1 ligoje |
| TRIP13thyroid hormone receptor interactor 13 | Kartais (5–29%) | 1 ligoje |
| UBAC2UBA domain containing 2 | Kartais (5–29%) | 1 ligoje |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Kartais (5–29%) | 1 ligoje |
| WWOXWW domain containing oxidoreductase | Kartais (5–29%) | 1 ligoje |
| ZBTB16zinc finger and BTB domain containing 16 | Kartais (5–29%) | 1 ligoje |
| ASAH1N-acylsphingosine amidohydrolase 1 | Retai (1–4 %) | 1 ligoje |
| COL1A1collagen type I alpha 1 chain | Retai (1–4 %) | 1 ligoje |
| PDGFBplatelet derived growth factor subunit B | Retai (1–4 %) | 1 ligoje |
| ACP5acid phosphatase 5, tartrate resistant | Neužfiksuota | 1 ligoje |
| ARPC1Bactin related protein 2/3 complex subunit 1B | Neužfiksuota | 1 ligoje |
| CARD9caspase recruitment domain family member 9 | Neužfiksuota | 1 ligoje |
| CD19CD19 molecule | Neužfiksuota | 1 ligoje |
| CYBAcytochrome b-245 alpha chain | Neužfiksuota | 1 ligoje |
| CYBBcytochrome b-245 beta chain | Neužfiksuota | 1 ligoje |
| ICOSinducible T cell costimulator | Neužfiksuota | 2 ligose |
| MCM4minichromosome maintenance complex component 4 | Neužfiksuota | 1 ligoje |
| NCF1neutrophil cytosolic factor 1 | Neužfiksuota | 1 ligoje |
| NCF2neutrophil cytosolic factor 2 | Neužfiksuota | 1 ligoje |
| POMPproteasome maturation protein | Neužfiksuota | 1 ligoje |
| PSMB4proteasome 20S subunit beta 4 | Neužfiksuota | 1 ligoje |
| SH2D1ASH2 domain containing 1A | Neužfiksuota | 1 ligoje |
| SMPD1sphingomyelin phosphodiesterase 1 | Neužfiksuota | 1 ligoje |
| TNFRSF13BTNF receptor superfamily member 13B | Neužfiksuota | 1 ligoje |
| TNFRSF13CTNF receptor superfamily member 13C | Neužfiksuota | 1 ligoje |
| XIAPX-linked inhibitor of apoptosis | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
- Swollen lymph nodes in center of chest36 genų
- Follicular hyperplasia16 genų
- Generalized swelling of lymph nodes14 genų
- Swollen lymph nodes in the neck14 genų
- Chronic noninfectious lymphadenopathy9 genų
- Axillary lymphadenopathy6 genų
- Inguinal lymphadenopathy6 genų
- Hilar lymph node enlargement1 genas
- Paratracheal lymphadenopathy1 genas
- Submandibular lymph node enlargement1 genas
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.17-8666dff2.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites